Condition
Juvenile Psoriatic Arthritis clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Juvenile Psoriatic Arthritis clinical trials that are recruiting, at sites in 18 countries (most in Spain (4), United States (3), Germany (3)). By phase: Phase 3 (4), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 18Countries
Newest Juvenile Psoriatic Arthritis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Evaluating Deucravacitinib for Juvenile Psoriatic Arthritis in Children | Phase 3 | Lancaster, California and 47 other locations | Recruiting | Mar 11, 2025 |
| Evaluating the safety and effectiveness of intravenous secukinumab in children with juvenile psoriatic arthritis. | Phase 1 | Loma Linda, California and 10 other locations | Recruiting | Dec 27, 2024 |
| Evaluating Bimekizumab for Pediatric Arthritis | Phase 3 | Calgary and 22 other locations | Recruiting | Oct 31, 2024 |
| Assessing the safety and effectiveness of risankizumab and adalimumab in children with juvenile psoriatic arthritis | Phase 3 | Little Rock, Arkansas and 33 other locations | Recruiting | Oct 25, 2023 |
| Using Apremilast to treat oral ulcers in children with Behçet's disease or juvenile psoriatic arthritis | Phase 3 | Thessaloniki and 6 other locations | Recruiting | Mar 14, 2023 |
All recruiting trials (5)
-
Evaluating Deucravacitinib for Juvenile Psoriatic Arthritis in Children
This study is testing if a new medication called Deucravacitinib can help children with juvenile psoriatic arthritis who haven't had success with other treatments.
-
Evaluating the safety and effectiveness of intravenous secukinumab in children with juvenile psoriatic arthritis.
This study is testing if an intravenous medication called secukinumab is safe and effective for children with juvenile psoriatic arthritis.
-
Evaluating Bimekizumab for Pediatric Arthritis
This study is testing a new medication called bimekizumab in children with certain types of arthritis to see if it is safe and effective for them.
-
Assessing the safety and effectiveness of risankizumab and adalimumab in children with juvenile psoriatic arthritis
This study is testing a new medication called risankizumab to see if it works better and is safer than the standard treatment adalimumab for children with juvenile psoriatic arthritis.
-
Using Apremilast to treat oral ulcers in children with Behçet's disease or juvenile psoriatic arthritis
This study is testing if the medication apremilast can safely help children with oral ulcers from Behçet's disease or juvenile psoriatic arthritis feel better over a longer time.
Related topics
Quick answers
How many Juvenile Psoriatic Arthritis clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 18 countries. The most sites are in Spain (4 trials), United States (3 trials), Germany (3 trials), Canada (2 trials), France (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 4, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.